AzTrials
AzTrials

Preoperative Clear Fluid FastingTimbarc-1NCT07288281

"Duration of Preoperative Clear Fluids Fasting in Patients Undergoing Liver Transplant"

An observational study of Preoperative Clear Fluid Fasting and Liver Transplant Recipient, run by Medical University of Warsaw at 1 site in Poland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

The goal of this prospective observational study is to report the duration of preoperative clear fluids fasting in patients undergoing liver transplant. It will also learn about the relationship between the duration of preoperative clear fluids fasting and changes in hemodynamic variables and metabolic profile at… Read more about this study

Who is it for?
Ages 18 years and older
How many people
100 participants
Where
1 sitePoland
Study dates
1 Jun 2025to 1 Feb 2026
How long will I take part?
1 Day
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with liver diseases scheduled for elective liver transplant at University Clinical Centre of Medical University of Warsaw

Who may be able to join

  • patients scheduled for elective liver transplant

Who cannot join

  • patients unable to give detailed answer on clear fluid fasting due to severe hepatic encephalopathy or cognitive impairment
  • lack of written informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Paula Dudek, Medical Doctor contact

+49225992001

paula.dudek@wum.edu.pl

Poland1 site, 1 recruiting
  • University Clinical Centre of Medical University of Warsaw

    Warsaw, Warszawa, 02-097

    Paula Dudek, medical doctor, +48225992001, paula.dudek@wum.edu.pl

    Recruiting

Other trials in Poland

About this study

Official title: "Duration of Preoperative Clear Fluids Fasting in Patients Undergoing Liver Transplant. A Prospective Observational Study: the "Timbarc-1" a Pilot Study"

The goal of this prospective observational study is to report the duration of preoperative clear fluids fasting in patients undergoing liver transplant. It will also learn about the relationship between the duration of preoperative clear fluids fasting and changes in hemodynamic variables and metabolic profile at various anesthesia and transplant phases. The main questions it aims to answer are:

  • How long liver recipient fast from clear fluids before liver transplant?
  • Is there any relationship between the duration of preoperative clear fluids fasting and changes in blood pressure and hear rate after the induction of anesthesia?
  • Is there any relationship between the duration of preoperative clear fluids fasting and blood glucose concentration, blood lactate concentration and acid base balance during anesthesia for liver transplant?
Read the detailed description

Clear fluids include water, certain juices without pulp (like apple or grape), clear sodas, tea or coffee without milk or cream, clear broth, sports drinks, gelatin, and popsicles without fruit pulp or yogurt.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07288281
Study groupRoleWhat they receive
liver recipientliver transplant recipient undergoing liver transplantation in University Clinical Center of Medical University of Warsaw

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. clear fluids fasting

    duration of preoperative clear fluids fasting in patients undergoing liver transplant

    Measured: before the induction of anesthesia

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2025
  2. Study start1 Jun 2025
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion1 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07288281
Sponsor's protocol ID
KB/67/2025
Acronym
Timbarc-1
Status last verified
Jun 2025
First submitted
4 Dec 2025
Last updated
7 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in